By using the dual screening approach, drug developers can identify new targets ... and the race to the market needs a rapid turnaround of data. Capacity can be a challenge, even for companies ...
Extensively drug-resistant (XDR-TB ... statement in 2008 for the use of molecular line-probe assays for the rapid screening of patients at risk of MDR-TB. This was extended to 27 countries ...
INBS' fingerprint sweat-based system enables Quantum TM to conduct on-the-spot drug screening in-house, facilitating rapid decision-making and improved operational efficiency. “The Intelligent ...
According to Grand View Research, the European and Middle Eastern drug screening markets are projected to grow significantly by 2030, with Europe expected to reach $3.6 billion 1 and the Middle East ...
Intelligent Bio Solutions Inc (NASDAQ:INBS) announced that Quantum Traffic Management, a U.K.-based traffic management provider, has adopted INBS Intelligent Fingerprinting Drug Testing Solution ...
(Nasdaq: INBS) ("INBS” or the "Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced plans for a major upgrade to its Intelligent ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果